Search results
13 paź 2014 · Cats in group 1 (n = 15) received intravenous infusion of insulin with the goal of maintaining blood glucose concentrations at 90–180 mg/dL, for 6 days. Cats in group 2 (n = 15) received subcutaneous injections of insulin glargine (cats ≤4 kg: 0.5–1.0 IU, q12h; >4 kg 1.5–2.0 IU, q12h), for 6 days.
20 lut 2015 · For these cats, a short-acting insulin preparation (eg, regular/soluble insulin) is generally given either intramuscularly (IM) or by intravenous infusion. 114 If regular/soluble insulin is not available, it has been suggested that glargine may also be given IM or intravenously (IV), 115 although good data on its efficacy by these routes is ...
4 maj 2021 · A pilot study comparing a protocol using intermittent administration of glargine and regular insulin to a continuous rate infusion of regular insulin in cats with naturally occurring diabetic ketoacidosis. J Vet Emerg Crit Care. 2015; 25:234‐239. [Google Scholar]
2 lip 2024 · Sodium-glucose cotransporter-2 (SGLT2) inhibitors are routinely used in the management of human type 2 diabetes and have been shown to effectively mitigate hyperglycemia and reduce the risks of cardiovascular and renal compromise.
15 paź 2024 · The implantable subcutaneous pump, telemetrically controlled by a smartphone, easily allowed the clinician to modify the type of administration and the amount of insulin delivered; the concurrent use of a CGMS allowed detection of sudden changes in blood glucose while limiting stress to the cat.
2 paź 2023 · Glargine, a common long-acting insulin analog used in cats, is an effective subcutaneous at-home therapy, and in humans, has comparable effects to regular insulin when given intravenously or intramuscularly. Glargine has been successfully used as a subcutaneous-intramuscular combination (basal-bolus) in cats in DKA in a previous study.
13 paź 2014 · Intensive Intravenous Infusion of Insulin. In group 1, blood glucose concentrations decreased to the target range within 12 hours of initiation of treatment in 13 of 15 cats. In those cats, it was necessary to reduce the insulin infusion rate to 0.02–0.03 IU/kg/h to avoid hypoglycemia.
